ScitoVation logo
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote

Blog

Featured image for “What are NAMs?”
June 29, 2021

What are NAMs?

Read More
Featured image for “The Frontier of Aerosol Safety Testing with In Vitro and in Silico Methods”
June 23, 2021

The Frontier of Aerosol Safety Testing with In Vitro and in Silico Methods

Read More
Featured image for “Why ScitoVation is Part of my Journey”
June 15, 2021

Why ScitoVation is Part of my Journey

Read More
Featured image for “Toward an Actionable Collaborative Data System for Toxicology”
June 9, 2021

Toward an Actionable Collaborative Data System for Toxicology

Read More
Featured image for “Updated Guidance from OECD on Reporting PBPK Models for Risk Assessment”
June 1, 2021

Updated Guidance from OECD on Reporting PBPK Models for Risk Assessment

Read More
Featured image for “Using Cells and Mathematical Models to Interpret Thyroid Hormone Disruption”
May 25, 2021

Using Cells and Mathematical Models to Interpret Thyroid Hormone Disruption

Read More
Featured image for “Using Short-term In Life Transcriptomic Studies to More Effectively Assess Dose Responses and Modes of Action”
May 18, 2021

Using Short-term In Life Transcriptomic Studies to More Effectively Assess Dose Responses and Modes of Action

Read More
Featured image for “Guidelines for assessing Pharmacokinetic Bias in Epidemiology”
May 13, 2021

Guidelines for assessing Pharmacokinetic Bias in Epidemiology

Read More
Featured image for “Better alternative models for risk assessment: In vitro inhalation toxicity assay and dosimetry modeling”
May 5, 2021

Better alternative models for risk assessment: In vitro inhalation toxicity assay and dosimetry modeling

Read More
Prev 1 2 3 4 Next
Contact Us

6 Davis Drive, Suite 146,
Durham, NC 27709

© 2025 ScitoVation. Privacy Policy
  • Services
    • Common Problems We Solve
      • Predicting Equivalent Dose in Humans
      • Understanding the Mode of Action of a Compound
      • Screening and Assessing Lead Compounds
    • Technologies
      • In vitro to in vivo extrapolation (IVIVE)
      • PBPK Modeling
      • Toxicogenomic or Pharmacogenomic Studies
    • Organ Specific
      • Liver toxicity
      • Respiratory Toxicity
      • Thyroid toxicity
    • Industries
      • Chemical Manufacturers and Consumer Products
      • Industry Associations
      • Pharma
  • Publications
  • Tools
    • MoAVIZ
    • PLETHEM
    • TTC Data Mart
  • Resources
    • Blog
    • Webinar
    • Case Studies
  • About us
    • Our Story
    • Team
    • Mission, Vision, Values
    • Careers
    • Scitovation, LLC. PHS-Financial Conflict Of Interest (FCOI) Policy
    • News
  • Request For Quote